ECElisete Isabel Crocco

Elisete Isabel Crocco

*This is an algorithmically generated author record based on publicly available information.

Elisete Isabel Crocco has a total of 74 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Acne unfiltered: expert discussions on stigma and solutions

    by Alison M Layton, Christine Bundy, Ncoza Dlova, Jacek Szepietowski, Elisete Crocco

    Acne is a common, inflammatory skin disease with global prevalence approaching 9% and affects many millions of people worldwide.1 Although frequently dismissed as a transient ‘rite of passage’ in teenagers who are most frequently affected, acne can persist for many years and aligns with the World Health Organization’s criteria of a chronic disease.2 Acne may also lead to long-standing hyperpigmentation and indelible scarring. These sequelae generate a profound, long-lasting psychosocial burden which is often worse than that caused by the original acne and may extend well beyond the course of the active acne lesions.3 Patients often perceive the clinical sequelae as more distressing than the active acne. The clinical sequelae are notoriously hard to treat, amplify psychosocial burden and are frequently more pronounced in skin of colour.

  • Open Access

    Topical oxybutynin antiperspirant for axillary hyperhidrosis: a phase IIb PROBE design clinical trial (TODAY trial)

    by Samantha Neves, Elisete Isabel Crocco, Viviane Santana da Silva, Felipe Menegueti, Alexia Paganotti, Ricardo Sanchez Boix, Nelson Wolosker, Roberto Augusto Caffaro

    Background Primary hyperhidrosis is a chronic condition with limited therapeutic options. Objectives To evaluate the impact of 10% oxybutynin spray on axillary hyperhidrosis, considering both its local and systemic effects, in terms of Hyperhidrosis Disease Severity Scale (HDSS) outcomes for hyperhidrosis of the axilla and eight additional sites. Methods Prospective phase II PROBE design trial. Adult patients with axillary hyperhidrosis were randomized to receive a 10% oxybutynin topical spray, oral oxybutynin, or placebo spray for 35 days. Efficacy was evaluated on day 35 using the HDSS and a hyperhidrosis-specific quality-of-life (QoL) assessment questionnaire. Results 17 patients were randomized. No significant differences were observed in HDSS outcomes from baseline to day 35 in any of the three groups (2.5 [2 - 4], 4 [3 - 4], 3.5 [3 - 4], p= 0.207), although a trend to improvement was noted in both treatment groups. Significant improvement in the QoL questionnaire was observed from baseline to day 35 in the oxybutynin spray group (pre-intervention QoL: 78.5 [70 - 96] and post-intervention QoL: 38.5 [32 - 67], p = 0.031). Conclusions No differences were observed in the primary outcome. A significant improvement from baseline to day 35 was observed in the QoL questionnaire score for the oxybutynin spray group.

  • Impact of Unlawful Aesthetic Practices in Brazil: A Multicenter Survey on Complications and the Need for Regulatory Reform

    by Gisele Viana de Oliveira, Annia Alves Rodrigues Cordeiro, Luanna Caires Portela, Doris Hexsel, Eliandre Palermo, Flavia Naranjo Ravelli, Gabriela Munhoz, Giselle Seabra, Rosemarie Mazzuco, Heliana Freitas de Oliveira Goes, et al.

    BACKGROUND: The illegal practice of medicine in aesthetic procedures poses significant public health risks because of complications from unqualified individuals. Invasive treatments such as botulinum toxin and fillers are frequently performed by nonmedical professionals without proper medical training, resulting in infections, necrosis, and lasting sequelae. OBJECTIVE: This study aimed to analyze the complications from nonphysicians encountered by Brazilian specialists (dermatologists, plastic surgeons, and other specialists) in their clinical practice. MATERIALS AND METHODS: A multicenter survey involving 1,058 physicians (primarily dermatologists and plastic surgeons) across Brazil assessed complications from aesthetic procedures performed by nonmedical individuals. Descriptive statistics categorized complications by type and severity, identified responsible practitioners, and estimated the health care and economic burdens. RESULTS: Over half of the respondents treat more than 100 patients monthly, and 12.69% of patients had undergone procedures by nonmedical professionals. On average, five complications were treated monthly per physician; 17% led to permanent sequelae. Common issues included scarring (78.68%), inflammation (72.15%), and infection (65.43%). Most cases required up to 3 specialists and 7 to 8 consultations per year, often involving multiple surgeries. CONCLUSION: These findings underscore the urgent need for regulatory enforcement, public education, and legal protection. Brazil's experience may inform other countries confronting similar issues related to the unauthorized practice of aesthetic medicine.


  • Open Access

    Reflectance confocal microscopy and clinical evaluation of a product containing Silybum marianum fruit extract in monotherapy for acne vulgaris treatment: A prospective study

    by Elisete I. Crocco, Renata O. Alves, Gustavo S. M. Carvalho, Rebeca R. A. Silva, Ricardo S. B. Silva, Karina B. C. V. Calbucci, Ana L. F. Coutinho, Christiano S. Andrade, Juliana C. T. Braga

    Background: Acne is a common pilosebaceous unit chronic inflammatory disease, with a multifactorial pathogenesis. It involves several processes: increased sebum production, alteration of the follicular keratinization process and bacterial colonization by Cutibacterium acnes.Objectives: To evaluate the effectiveness of reflectance confocal microscopy (RCM) in evaluating the reduction of mild to severe acne lesions in patients treated with an investigational product containing Silybum marianum fruit extract (SMFE).Methods: Subjects previously examined for counting acne lesions were topically treated in the face, with an investigational product containing SMFE in monotherapy over the course of 60 days (n = 31). They were examined for counting acne lesions. Efficacy and quality of life, tolerability, and safety assessments were performed. The infundibular diameter (ID) measurement of normal and acne skin areas was analyzed using RCM.Results: The RCM data statistical analysis allowed us to identify two ID patterns, 300–750 µm, with a reduction of 33.33% (p < 0.05) and 900–1050 µm with 73.16% (p < 0.05) reduction after 60 days. The noninflammatory lesions had a mean variation of −44.51% and −67.82% after 30 and 60 days, respectively (t test: p < 0.05 and p < 0.001 after Bonferroni's correction). The inflammatory lesions had a mean variation of −69.31% and −79.40% after 30 and 60 days (t test: p < 0.05 and p = 0.118 after Bonferroni's correction).Conclusions: The authors demonstrated the effectiveness of the monotherapy scheme with an investigational product containing SMFE through the statistically significant results obtained by the RCM in acneic and nonacneic skin, in addition to the reduction in the number of noninflammatory at the end of the 60 days of clinical follow‐up. Furthermore, the monotherapy scheme with the investigational product proved safe, with no serious adverse events during the entire clinical study. In summary, the use of RCM proved to be effective in assessing the therapeutic response in patients with moderate to severe acne.


  • Open Access

    3:2 proportion eye‐opening technique using 2 mL of hyaluronic acid filler

    by Elisete Isabel Crocco, Karina Baruel de Camargo Votto Calbucci, Rossana Cantanhede Farias Vasconcelos, Anna Carolina Brandão Vasconcelos

  • Open Access

    Combination of 5% cysteamine and 4% nicotinamide in melasma: Efficacy, tolerability, and safety

    by Elisete Isabel Crocco, Liliana Torloni, Paula Bonilha Fernandes, Maria Elisa Barbosa Bueno de Campos, Maura Gonzaga, Fernanda Cristina Silva, João Paulo Sardin Nasario, Lucas Offenbecker Guerra, Angélica Richart Csipak, Vivienne Carduz Castilho

    Background: Melasma is a chronic dermatosis that impacts the patient's quality of life and can present considerable challenges in terms of effective treatment. Objective: To evaluate the effectiveness, tolerability, and safety of 5% cysteamine combined with 4% nicotinamide in female subjects with melasma. Methods: This single‐center, single‐arm, prospective, open‐label study evaluated patients with melasma using a combination cream of 5% cysteamine and 4% nicotinamide in a progressive regimen (60 min in the first month, 120 min in the second month, and 180 min in the third month). Results: Overall, 35 treated subjects exhibited reduced modified Melasma Area and Severity Index (mMASI) ( p < 0.001) and decreased MelasQoL scores ( p < 0.001), accompanied by improved brightness, luminosity, homogeneity, and spot intensity ( p < 0.001). Photographic and colorimetric analysis revealed smaller spots and improved homogeneity. Limitations: Adherence to progressive daily treatment could not be evaluated long‐term. Conclusion: A combination cream comprising 5% cysteamine and 4% nicotinamide was effective, tolerable, and safe for treating melasma.


  • Modulation of skin androgenesis and sebum production by a dermocosmetic formulation

    by Elisete Isabel Crocco, Evellin Barbosa Bonifácio, Gustavo Facchini, Gustavo Henrique da Silva, Michelle Sabrina da Silva, Ana Lucia Tabarini Alves Pinheiro, Paula Voltarelli Franco Avelar, Samara Eberlin

    Background Excessive androgenesis in the skin promotes sebaceous hyperproduction which is the onset of acne vulgaris pathogenesis. Free fatty acids and lipids accumulation in the glandular infundibulum culminates in microbiota imbalance, triggering inflammatory response and follicular hyperkeratinization. Aims The purpose of this work was to present an alternative cosmetic treatment for acne skin care, focusing on the prevention of sebaceous gland dysregulation. Methods Insulin‐stimulated human sebocytes were treated with non‐cytotoxic concentrations of a DTRW cosmetic formulation. After 6 days of incubation, cell lysates were collected for testosterone, 5α‐reductase and dyhidrotestosterone (DHT) quantitation. In parallel, cells were stained with Oil Red O to measure sebum production. Results Human sebocytes were incubated with insulin to mimic a seborrheic microenvironment with overproduction of intracellular lipids and fatty acids. Concomitant incubation of cell cultures with DRTW was able to promote a 52.97% reduction in intracellular lipid content. The anti‐androgenic properties of DRTW had been proved by the reductions of testosterone (↓59.90%), 5α reductase (↓59.34%) and DHT (↓55.98%) levels in sebocyte cultures also stimulated with insulin. Conclusion The results indicate a promising action of DRTW cosmetic formulation in preventing the development of acne lesions by mechanisms involving the modulation of cutaneous androgenesis and consequently the control of sebum overproduction, considered one of the leading cause of acne.


  • Open Access

    Tratamento da poroqueratose actínica superficial disseminada com laser 1340-nm Nd:YAP

    by Rodolfo Ferreira Mendonça, Lyvia Almeida Nascimento Salem, Renata Oliveira Alves, Bomi Hong, Rute Facchini Lellis, Elisete Isabel Crocco

    Revista Online - Surgical & Cosmetic Dermatology | Publicação oficial da Sociedade Brasileira de Dermatologia, a segunda maior sociedade dermatológica do mundo com mais de 5.000 associados, o periódico Surgical & Cosmetic Dermatology, editada em 2009, constitui publicação médica destinada a difundir a experiência brasileira nas áreas de Cirurgia Dermatológica e Cosmiatria. É uma publicação trimestral das Sociedades Brasileiras de Dermatologia e de Cirurgia Dermatológica.